
|Videos|January 27, 2021
Visus CEO updates on lead product candidate, 2021 pipeline
Author(s)OT Staff Reports
Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseases
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Starting from scratch on neovascular age-related macular degeneration
4
Subretinal drusenoid deposits in Black and Hispanic patients with AMD
5